Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeVertex Pharmaceuticals

      Vertex Pharmaceuticals

      Vertex Stock: the Next Blockbuster Drug Stock to Invest In?
      Investing News

      Vertex Stock: the Next Blockbuster Drug Stock to Invest In?

      February 23, 2024
      Vertex Reports Robust Growth Fueled by Trikafta/Kaftrio; Fair Value Estimate Raised 3%
      Investing News

      Vertex Reports Robust Growth Fueled by Trikafta/Kaftrio; Fair Value Estimate Raised 3%

      August 7, 2023
      FDA Approves Vertex’s CF Drug for Toddlers
      Investing News

      FDA Approves Vertex’s CF Drug for Toddlers

      September 5, 2022
      Vertex Improves Revenue Guidance For 2022 Due To Q2 Top And Bottom-Line Gains
      Investing News

      Vertex Improves Revenue Guidance For 2022 Due To Q2 Top And Bottom-Line Gains

      August 5, 2022

       

      LATEST NEWS

      • Investing News Merck Q1 2026 Earnings Report Review
      • Investing News Eli Lilly Q1 2026 Earnings Analysis
      • Investing News Microsoft Reports Strong Q3 Earnings
      • Investing News Meta’s Q1 2026 Earnings Overview
      • Investing News NXP Semiconductors’ Earnings Exceed Expectations

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026